GOSSELIES, Belgium and NANTES, France, Oct. 30, 2025 /PRNewswire/ -- AbolerIS Pharma ("AbolerIS"), a clinical-stage biopharmaceutical company committed to improving the lives of people suffering from autoimmune and inflammatory diseases, today announced the appointment of Philippe Alen as...
AbolerIS Pharma Appoints Seasoned Life-Sciences Executive Philippe Alen as Chief Business Officer
Seeking Alpha / 11 hours ago 1 Views
Comments